| Cancer type | Expression | Cell line | Role | Biological function | Related genes and protein | Reference |
| Glioma | Downregulated | U251, A172 | Suppressor | Suppress proliferation, migration, and invasion and promote apoptosis | miR-4262 increased, | [18] | NF-κB pathway activated | p-NF-κB p65 and IκBα activated | Breast cancer | Downregulated | MDA-MB-415, MCF7 | Suppressor | Suppress proliferation, colony formation, migration, and invasion | miR-197-3p increased, Sufu decreased | [20] | MAPK pathway activated | Thyroid cancer | Upregulated | MDA-T32, MDA-T68 | Oncogenic | Promote proliferation, migration, invasion, | Cyclin B1 increased, CDK1 increased | [19] | Promote cell cycle | MMP2 increased, MMP9 increased | Lung cancer | Downregulated | A549, H1299, PC-9, H1975 | Suppressor | Suppress migration and invasion | miR-942-5p increased, ZNF471 decreased | [22] | Gastric cancer | Upregulated | BSG823, BGC803 | Oncogenic | Promote proliferation, migration, and invasion and suppress apoptosis | miR-29a-3p decreased, COL1A2 increased | [23, 24] | | Downregulated | MKN45, AGS | Suppressor | Suppress proliferation, migration, and invasion | miR-4698 increased, MTUS1 decreased, MEK/ERK pathway inhibited | [25] | Colorectual cancer | Upregulated | HCT116 | Oncogenic | Promote proliferation and suppress apoptosis | miR-29a decreased, TNFAIP3, miR-182 decreased, miR-106a decreased, miR-372 decreased, miR-144 decreased, miR-206 decreased | [29–31] | Osteosarcoma | Upregulated | U20S, 143B | Oncogenic | Promote proliferation and invasion and suppress apoptosis | miR-29a increased, NFIA decreased | [42] |
|
|